Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Current Assets of $3.2 billion for Q1 2026, up 9.94% year-over-year from $2.9 billion in Q1 2025, and up 9.94% quarter-over-quarter from $2.9 billion in Q1 2025.
Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Current Assets history runs 10 years deep, the most recent figure standing at $3.2 billion for Q1 2026.
- In Q1 2026, Current Assets rose 9.94% year-over-year to $3.2 billion; the TTM figure through Mar 2026 stood at $3.2 billion (up 9.94% YoY), while the FY2026 annual figure was $3.2 billion, up 9.94% from the prior year.
- Current Assets for Q1 2026 stood at $3.2 billion, up from $2.9 billion in the prior quarter.
- The five-year high for Current Assets was $3.2 billion in Q1 2026, with the low at $2.4 billion in Q1 2022.
- The 5-year median for Current Assets is $2.9 billion (2025), against an average of $2.8 billion.
- The sharpest annual moves came in 2022 and 2025: Current Assets gained 18.25% in 2022, then slipped 1.61% in 2025.
- Dr Reddys Laboratories' Current Assets stood at $2.4 billion in 2022, then rose by 5.05% to $2.5 billion in 2023, then rose by 18.19% to $3.0 billion in 2024, then slipped by 1.61% to $2.9 billion in 2025, then advanced by 9.94% to $3.2 billion in 2026.
- Business Quant data shows RDY's Current Assets at $3.2 billion in Q1 2026, $2.9 billion in Q1 2025, and $3.0 billion in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 1.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.22 Bn |
| Mar 31, 2025 | 2.93 Bn |
| Mar 31, 2024 | 2.98 Bn |
| Mar 31, 2023 | 2.52 Bn |
| Mar 31, 2022 | 2.40 Bn |
| Mar 31, 2021 | 2.03 Bn |
| Mar 31, 2020 | 1.73 Bn |
| Mar 31, 2019 | 1.66 Bn |
| Mar 31, 2018 | 1.68 Bn |
| Dec 31, 2009 | 804.00 Mn |
| Sep 30, 2009 | 785.00 Mn |
| Jun 30, 2009 | 824.00 Mn |